News & Press

Keep up with the latest news and press releases from SHARx.

  • Pro Basketball Star Sophie Cunningham Promotes Accessible Prescription Drugs
    Viral sensation and SHARx brand ambassador Sophie Cunningham generated widespread media attention through her partnership with SHARx, with coverage across…
    Read More

  • Small Businesses Are Rebelling Against Hidden Drug Benefit Costs
    As healthcare costs continue to rise, small businesses can’t keep up. Business owners struggle with a lack of transparency in…
    Read More

  • Drug Cost Spiral Breaks Employer Benefit Plans
    Rising drug costs and opaque PBM practices are forcing employers to treat prescription benefits as enterprise risk. In 2026, U.S….
    Read More

  • The GLP-1 Effect: How Weight-Loss Drugs Are Changing the Business of Healthcare
    This Cheddar segment explores the growing impact of GLP-1 medications on healthcare, highlighting how these drugs are reshaping conversations around…
    Read More

  • SHARx CEO Warns Companies May Be Overlooking Their Biggest Cost Driver in Healthcare
    As healthcare and pharmacy costs surge, employers are under pressure to protect their workforce without sacrificing financial stability. SHARx CEO…
    Read More

  • Holding patients hostage: Why drug prices in the US are higher than ever
    Rising drug costs are an increasingly important priority in the US. Americans spend more on healthcare than any other country…
    Read More

  • SHARx Calls for Accountability as Policymakers Target PBM Practices Nationwide
    Rising drug costs and persistent access barriers are prompting employers to scrutinize the role of PBMs in determining how care…
    Read More

  • SHARx: Drug Pricing Isn’t Just Broken, It’s Protected
    Growing regulatory scrutiny and industry reporting suggests that high drug prices persist not just because of cost, but because of…
    Read More

  • SHARx Analyzes TrumpRx: Transparency on Drug Costs Doesn’t Resolve Pricing and Access Gatekeeping
    The launch of the TrumpRx platform has put prescription drug pricing back in the spotlight, but lower list prices are…
    Read More

  • Business Insight Journal Interview with Paul Pruitt, Co-founder and Chief Growth Officer at SHARx
    Paul Pruitt, co-founder of SHARx, argues that the U.S. drug affordability crisis is driven by a lack of transparency and…
    Read More

News & Press Inquiries

Send inquiry